CIK 0001348362
- Non-accelerated filer
- Smaller reporting company
Lexaria Bioscience Corp.
Sign in to watch- Ticker
- LEXX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Aug 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 202000871
- Phone
- +1 250-765-6424
- Business address
- 100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
- Former names
- Lexaria Corp., LEXARIA CORP.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-14 | Downey Gregory Chief Financial Officer | Purchase | +121 | $2.09 | $253 | 1,954 |
| 2022-10-14 | Downey Gregory Chief Financial Officer | Grant or award | +121 | $2.09 | $253 | 1,954 |
| 2022-08-29 | Downey Gregory Chief Financial Officer | Grant or award · Stock Options | +11,000 | 46,000 | ||
| 2021-09-01 | Downey Gregory Chief Financial Officer | Grant or award · Stock Options | +10,000 | 35,000 | ||
| 2021-06-08 | Downey Gregory Chief Financial Officer | Grant or award · Stock Options | +8,000 | 25,000 | ||
| 2021-05-07 | Downey Gregory Chief Financial Officer | Other disposition · Stock Options | −8,000 | 17,000 | ||
| 2021-04-26 | Downey Gregory Chief Financial Officer | Grant or award · Stock Options | +5,000 | 25,000 |
Page 1 of 1 · 7 trades